ArticleCureus2025
Comparative Effectiveness of Carbetocin Versus Oxytocin in Active Management of the Third Stage of Labour for Preventing Atonic Postpartum Haemorrhage: A Study at a Tertiary Care Centre in Central India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionWe aim to determine the comparative effectiveness of heat-stable carbetocin (HSC) versus oxytocin for the prevention of atonic postpartum haemorrhage (PPH) at a tertiary care centre in Central India.
methodThis study is a prospective observational study conducted over 18 months (January 2023 to July 2024) and included 284 low-risk gravid women in labour at term after obtaining ethical approval and informed consent. There were 142 participants in each group. Group 1 received heat-stable carbetocin 100 mcg, and group 2 received oxytocin 10 units intramuscularly within one minute of delivery. Women with medical or obstetrical disorders were excluded. The primary objective was to compare the incidence of atonic PPH among participants receiving carbetocin versus oxytocin after the delivery of the baby. The secondary objective was to estimate the mean blood loss (MBL) and change in the haemoglobin (Hb) level before and after delivery in the two groups. Blood loss was estimated by quantifying blood loss by adding up the volumetric component (using a calibrated drape or suction bottle) to the gravimetric estimate. The incidence of PPH and the mean blood loss were noted. The degree of haemoglobin decline before and after delivery was also recorded. Statistical significance was assessed using Student's t-test and chi-square test, and a p-value of <0.05 was taken as significant.
resultThe incidence of PPH was comparatively less in women in the carbetocin group (group 1) when compared with those in the oxytocin group (group 2), although not statistically significant (4.2% versus 7%, respectively; p=0.303). A significant difference was observed in the mean blood loss, being less with carbetocin (623±81.3 versus 678±88.7 mL; p=0.039). Haemoglobin decline was also found to be less in those receiving carbetocin (p<0.001).
conclusionAlthough insignificant statistically, carbetocin plays an effective role in preventing PPH when compared to oxytocin, particularly in settings where cold chain maintenance for oxytocin transport and storage remains doubtful. Statistically significant lower mean blood loss with carbetocin can be an added advantage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.